SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-001685
Filing Date
2015-01-12
Accepted
2015-01-12 07:00:30
Documents
7
Period of Report
2015-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-2148_18k.htm 8-K 56236
2 EX-2.1 a15-2148_1ex2d1.htm EX-2.1 545604
3 EX-3.2 a15-2148_1ex3d2.htm EX-3.2 260865
4 EX-10.1 a15-2148_1ex10d1.htm EX-10.1 159379
5 EX-99.1 a15-2148_1ex99d1.htm EX-99.1 91261
6 GRAPHIC g21611mm01i001.gif GRAPHIC 6163
7 GRAPHIC g21611mm01i002.gif GRAPHIC 2840
  Complete submission text file 0001104659-15-001685.txt   1127444
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 15520592
SIC: 2836 Biological Products, (No Diagnostic Substances)